Navigation Links
Alere Inc. Announces Hiring of Namal Nawana as Chief Operating Officer
Date:12/12/2012

WALTHAM, Mass., Dec. 12, 2012 /PRNewswire/ -- Alere Inc. (NYSE: ALR) (the "Company") announced today the appointment of Namal Nawana as its new Chief Operating Officer, effective December 30, 2012. Mr. Nawana comes to Alere from Johnson & Johnson, where he has spent 15 years in various leadership roles, spanning the fields of engineering, marketing, sales and general management, including in Canada, Europe, the United States and the Asia Pacific region. At Alere, Mr. Nawana will be responsible for all commercial, R&D and operational functions, globally.

Mr. Nawana's experience before and at Johnson & Johnson  has earned him a reputation as a strategist, an innovator and a global operations leader focused on scaling businesses profitably. Most recently, Mr. Nawana served as the Worldwide President of DePuy Synthes Spine, a Johnson & Johnson company, responsible for, among other things, managing all operations globally. Prior to that, he was Area Vice President for Johnson & Johnson Medical's operations in Australia and New Zealand, Chairman of the DePuy Asia Pacific Franchise Council, General Manager for DePuy Australia and General Manager for Depuy Canada. Through these roles, Mr. Nawana demonstrated a consistent track record of delivering year over year results.  During this time, Mr. Nawana was responsible for the planning and integration of numerous significant business acquisitions, and he played a key role in integrating the multi-billion dollar Synthes acquisition.

"Namal's extensive experience driving improvement and change within a global medical device manufacturer on the scale of DePuy Synthes Spine, and in particular his experience leading complex business integrations, fits perfectly with Alere's needs as worldwide provider of healthcare solutions which has experienced extraordinary growth through acquisitions," said Ron Zwanziger, Alere's Chief Executive Officer. "Namal's appointment demonstrates our commitment to improving execution at all levels. Just as important, Namal's visionary leadership and expertise in operational integration will aid Alere in delivering products which not only provide reliable diagnostics but also incorporate connectivity technologies that put patients in touch with caregivers on a real-time basis."

Mr. Nawana holds an Honours Degree in Mechanical Engineering (1992), a Masters of Medical Science from the University of Adelaide in South Australia (1995), and a MBA from the Henley Business School in the United Kingdom (2000). Additionally, Mr. Nawana achieved Six Sigma Process Excellence Black Belt certification through Johnson and Johnson and also Chartered Professional Engineer qualifications from the Institution of Engineers Australia.

Cautionary Note Regarding Forward-Looking Statements

This press release contains forward-looking statements within the meaning of the federal securities laws, including statements regarding the expected offering and the use of proceeds. These statements reflect Alere's current views with respect to future events and are based on management's current assumptions and information currently available. Actual results may differ materially due to numerous factors including, without limitation, risks associated with market and economic conditions. Alere undertakes no obligation to update any forward-looking statements contained herein.

About Alere Inc.

By developing new capabilities in near-patient diagnosis, monitoring and health management, Alere enables individuals to take charge of improving their health and quality of life at home. Alere's global leading products and services, as well as its new product development efforts, focus on cardiology, infectious disease, toxicology, diabetes, oncology and women's health. Alere is headquartered in Waltham, Massachusetts.

For additional information on Alere, please visit www.alere.com


'/>"/>
SOURCE Alere Inc.
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Alere Inc. Announces Early Results of its Tender Offer and Consent Solicitation for Any and All of its 7.875% Senior Notes due 2016
2. Alere Inc. Announces Offering of $450 Million of Senior Notes
3. Northwest Biotherapeutics, Inc. Announces Full Exercise of Over- Allotment Option
4. Cadence Pharmaceuticals Announces Termination of Option Agreement to Acquire Incline Therapeutics, Inc.
5. River Vision Announces Completion of $17 million Series A Financing
6. Winner Medical Announces Closing of Going Private Transaction
7. IDEXX Laboratories Announces Entry Into Consent Agreement with FTC Bureau of Competition Staff
8. Valeant Completes Acquisition of Medicis and Announces Date of 2013 Financial Guidance Conference Call
9. Net Medical Xpress Announces Substantial Teleradiology Growth and Major New Opportunities in Diagnostic/Clinical Crossover Care
10. Maine Manufacturing, LLC Announces the Acquisition of Laboratory Filter and Membrane Business from GE
11. Xstelos Holdings Announces Dividend
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/19/2017)... April 19, 2017 Global Surgical Drainage Device ... tubes used to remove excess liquid and air. The ... urine, bile or lymph. Surgical drains are used in ... as orthopedics surgery, cardiovascular surgery, neurosurgery, plastic surgery etc. ... to prevent accumulation of fluid e.g. blood or pus. ...
(Date:4/19/2017)... 19, 2017  Sorrento Therapeutics, Inc. (NASDAQ: ... company developing new treatments for cancer and other ... its previously announced underwritten public offering of 23,625,084 ... offering price of $2.00 per share, before deducting ... payable by Sorrento.  The net proceeds to Sorrento ...
(Date:4/19/2017)... , April 19, 2017  SARES•REGIS Group ... it is developing at Conejo Spectrum Business Park ... to Atara Biotherapeutics, Inc. , a biopharmaceutical ... and life-threatening diseases that have been underserved by ... T-cell therapies for cancer, autoimmune and infectious disease. ...
Breaking Medicine Technology:
(Date:4/26/2017)... ... April 26, 2017 , ... Bioclinica® ... sponsors and CROs to speed clinical development, has released the industry’s only ... Bioclinica AGILE RTSM provides seamless clinical supply forecasting and management together ...
(Date:4/25/2017)... KY (PRWEB) , ... April 25, 2017 , ... ... announce they have signed an agreement to be the preferred physical therapy provider ... injuries and returning them to Derby City CrossFit as quickly and effectively as ...
(Date:4/25/2017)... ... April 25, 2017 , ... A recent report from the ... for the 2015-16 school year across Wisconsin’s public schools, charter schools, and private ... patterns in student test score performance, the report’s limited analyses fail to provide ...
(Date:4/25/2017)... ... 2017 , ... As pharmaceutical companies are held to increasingly ... innovation in drug formulation and manufacturing. CoreRx offers its clients more than ... support of their development and manufacturing goals. , The company was created ...
(Date:4/25/2017)... Scotch Plains, NJ (PRWEB) , ... April 25, 2017 , ... Saad B. Chaudhary, MD ... with the treatment of acute or chronic problems, I focus on preventative care with all ... patient. If you have any questions, always feel free to contact my office and my ...
Breaking Medicine News(10 mins):